Skip to main content
. 2023 Feb 21;15(5):1358. doi: 10.3390/cancers15051358

Figure 1.

Figure 1

MiRs associated with the detection of CRC and mCRC, the prediction of early relapse of CRC, and the prediction of responses to chemotherapy/radiotherapy/chemoradiotherapy in CRC and mCRC. Red words indicate the oncomiRs enhance chemoresistance/radioresistance and blue words indicate the anti-oncomiRs that enhance chemosensitivity/radiosensitivity in CRC and mCRC.